415 related articles for article (PubMed ID: 26193259)
21. Emerging therapies in Ewing sarcoma.
Strauss SJ; Berlanga P; McCabe MG
Curr Opin Oncol; 2024 Jul; 36(4):297-304. PubMed ID: 38775200
[TBL] [Abstract][Full Text] [Related]
22. A t(17;22)(q21;q12) with partial ETV4 deletion in a soft tissue Ewing sarcoma.
Rougemont AL; Bouron-Dal Soglio D; Patey-Mariaud de Serre N; Fetni R; Fan L; Barrette S; Fournet JC
Cancer Genet; 2012; 205(1-2):55-60. PubMed ID: 22429598
[TBL] [Abstract][Full Text] [Related]
23. Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma--associations with tumor phenotype and survival.
Tilan JU; Krailo M; Barkauskas DA; Galli S; Mtaweh H; Long J; Wang H; Hawkins K; Lu C; Jeha D; Izycka-Swieszewska E; Lawlor ER; Toretsky JA; Kitlinska JB
Cancer; 2015 Mar; 121(5):697-707. PubMed ID: 25387699
[TBL] [Abstract][Full Text] [Related]
24. Deep Sequencing in Conjunction with Expression and Functional Analyses Reveals Activation of FGFR1 in Ewing Sarcoma.
Agelopoulos K; Richter GH; Schmidt E; Dirksen U; von Heyking K; Moser B; Klein HU; Kontny U; Dugas M; Poos K; Korsching E; Buch T; Weckesser M; Schulze I; Besoke R; Witten A; Stoll M; Köhler G; Hartmann W; Wardelmann E; Rossig C; Baumhoer D; Jürgens H; Burdach S; Berdel WE; Müller-Tidow C
Clin Cancer Res; 2015 Nov; 21(21):4935-46. PubMed ID: 26179511
[TBL] [Abstract][Full Text] [Related]
25. The genomic landscape of pediatric Ewing sarcoma.
Crompton BD; Stewart C; Taylor-Weiner A; Alexe G; Kurek KC; Calicchio ML; Kiezun A; Carter SL; Shukla SA; Mehta SS; Thorner AR; de Torres C; Lavarino C; Suñol M; McKenna A; Sivachenko A; Cibulskis K; Lawrence MS; Stojanov P; Rosenberg M; Ambrogio L; Auclair D; Seepo S; Blumenstiel B; DeFelice M; Imaz-Rosshandler I; Schwarz-Cruz Y Celis A; Rivera MN; Rodriguez-Galindo C; Fleming MD; Golub TR; Getz G; Mora J; Stegmaier K
Cancer Discov; 2014 Nov; 4(11):1326-41. PubMed ID: 25186949
[TBL] [Abstract][Full Text] [Related]
26. Ewing tumor fusion proteins block the differentiation of pluripotent marrow stromal cells.
Torchia EC; Jaishankar S; Baker SJ
Cancer Res; 2003 Jul; 63(13):3464-8. PubMed ID: 12839926
[TBL] [Abstract][Full Text] [Related]
27. Exploiting Replication Stress as a Novel Therapeutic Intervention.
Martin JC; Hoegel TJ; Lynch ML; Woloszynska A; Melendy T; Ohm JE
Mol Cancer Res; 2021 Feb; 19(2):192-206. PubMed ID: 33020173
[TBL] [Abstract][Full Text] [Related]
28. BCOR-CCNB3 (Ewing-like) sarcoma: a clinicopathologic analysis of 10 cases, in comparison with conventional Ewing sarcoma.
Puls F; Niblett A; Marland G; Gaston CL; Douis H; Mangham DC; Sumathi VP; Kindblom LG
Am J Surg Pathol; 2014 Oct; 38(10):1307-18. PubMed ID: 24805859
[TBL] [Abstract][Full Text] [Related]
29. [Ewing/PNET sarcoma family of tumors: towards a new paradigm?].
Renard C; Ranchère-Vince D
Ann Pathol; 2015 Jan; 35(1):86-97. PubMed ID: 25534668
[TBL] [Abstract][Full Text] [Related]
30. Targeting the EWSR1-FLI1 oncogene-induced protein kinase PKC-β abolishes ewing sarcoma growth.
Surdez D; Benetkiewicz M; Perrin V; Han ZY; Pierron G; Ballet S; Lamoureux F; Rédini F; Decouvelaere AV; Daudigeos-Dubus E; Geoerger B; de Pinieux G; Delattre O; Tirode F
Cancer Res; 2012 Sep; 72(17):4494-503. PubMed ID: 22930730
[TBL] [Abstract][Full Text] [Related]
31. Osteosarcoma With Apparent Ewing Sarcoma Gene Rearrangement.
Mathias MD; Chou AJ; Meyers P; Shukla N; Hameed M; Agaram N; Wang L; Berger MF; Walsh M; Kentsis A
J Pediatr Hematol Oncol; 2016 Jul; 38(5):e166-8. PubMed ID: 27352193
[TBL] [Abstract][Full Text] [Related]
32. EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3.
Prieur A; Tirode F; Cohen P; Delattre O
Mol Cell Biol; 2004 Aug; 24(16):7275-83. PubMed ID: 15282325
[TBL] [Abstract][Full Text] [Related]
33. Synthetic siRNA targeting the breakpoint of EWS/Fli-1 inhibits growth of Ewing sarcoma xenografts in a mouse model.
Takigami I; Ohno T; Kitade Y; Hara A; Nagano A; Kawai G; Saitou M; Matsuhashi A; Yamada K; Shimizu K
Int J Cancer; 2011 Jan; 128(1):216-26. PubMed ID: 20648560
[TBL] [Abstract][Full Text] [Related]
34. Ewing sarcoma with 7;22 translocation: three new cases and clinicopathological characterization.
Shulman SC; Katzenstein H; Bridge J; Bannister LL; Qayed M; Oskouei S; Shehata BM
Fetal Pediatr Pathol; 2012 Dec; 31(6):341-8. PubMed ID: 22432475
[TBL] [Abstract][Full Text] [Related]
35. Proteasome Addiction Defined in Ewing Sarcoma Is Effectively Targeted by a Novel Class of 19S Proteasome Inhibitors.
Shukla N; Somwar R; Smith RS; Ambati S; Munoz S; Merchant M; D'Arcy P; Wang X; Kobos R; Antczak C; Bhinder B; Shum D; Radu C; Yang G; Taylor BS; Ng CK; Weigelt B; Khodos I; de Stanchina E; Reis-Filho JS; Ouerfelli O; Linder S; Djaballah H; Ladanyi M
Cancer Res; 2016 Aug; 76(15):4525-34. PubMed ID: 27256563
[TBL] [Abstract][Full Text] [Related]
36. Ewing sarcoma mimicking atypical carcinoid tumor: detection of unexpected genomic alterations demonstrates the use of next generation sequencing as a diagnostic tool.
Doyle LA; Wong KK; Bueno R; Dal Cin P; Fletcher JA; Sholl LM; Kuo F
Cancer Genet; 2014; 207(7-8):335-9. PubMed ID: 25441687
[TBL] [Abstract][Full Text] [Related]
37. Ewing Sarcoma, an Update on Molecular Pathology with Therapeutic Implications.
de Alava E
Surg Pathol Clin; 2017 Sep; 10(3):575-585. PubMed ID: 28797503
[TBL] [Abstract][Full Text] [Related]
38. Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations.
Tirode F; Surdez D; Ma X; Parker M; Le Deley MC; Bahrami A; Zhang Z; Lapouble E; Grossetête-Lalami S; Rusch M; Reynaud S; Rio-Frio T; Hedlund E; Wu G; Chen X; Pierron G; Oberlin O; Zaidi S; Lemmon G; Gupta P; Vadodaria B; Easton J; Gut M; Ding L; Mardis ER; Wilson RK; Shurtleff S; Laurence V; Michon J; Marec-Bérard P; Gut I; Downing J; Dyer M; Zhang J; Delattre O;
Cancer Discov; 2014 Nov; 4(11):1342-53. PubMed ID: 25223734
[TBL] [Abstract][Full Text] [Related]
39. Extraosseous Ewing sarcoma with foci of neuroblastoma-like differentiation associated with EWSR1(Ewing sarcoma breakpoint region 1)/FLI1 translocation without prior chemotherapy.
Vali K; Kokta V; Beaunoyer M; Fetni R; Teira P; Sartelet H
Hum Pathol; 2012 Oct; 43(10):1772-6. PubMed ID: 22703924
[TBL] [Abstract][Full Text] [Related]
40. Robust diagnosis of Ewing sarcoma by immunohistochemical detection of super-enhancer-driven EWSR1-ETS targets.
Baldauf MC; Orth MF; Dallmayer M; Marchetto A; Gerke JS; Rubio RA; Kiran MM; Musa J; Knott MML; Ohmura S; Li J; Akpolat N; Akatli AN; Özen Ö; Dirksen U; Hartmann W; de Alava E; Baumhoer D; Sannino G; Kirchner T; Grünewald TGP
Oncotarget; 2018 Jan; 9(2):1587-1601. PubMed ID: 29416716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
